Bill Leitner Drsc Mph

Bill Leitner DRSc, MPH has a diverse work experience in the pharmaceutical and biopharmaceutical industry. Bill currently serves as the Senior Director of Business Development at Aurinia Pharmaceuticals Inc. since August 2021, where they were previously the Director of Business Development from May 2020 to August 2021. Before joining Aurinia Pharmaceuticals Inc., they worked at Sienna Biopharmaceuticals as the Director of Corporate Strategy and Business Development from January 2016 to December 2019. Prior to that, they held the position of Associate Director Pharmacovigilance and Project Management at KYTHERA Biopharmaceuticals from August 2013 to January 2016. Bill also has experience at Allergan Medical, where they served as the Manager of Product Safety and Risk Management from June 2011 to August 2013, the Regulatory Affairs Specialist from March 2010 to June 2011, and the QA/QC Operations Manager from August 2006 to March 2010. Their earlier experience includes working as a Post Market Surveillance Specialist at Inamed from June 2004 to August 2006.

Bill Leitner DRSc, MPH has a diverse education history. Bill began their academic journey at UC Santa Barbara from 1995 to 1999, where they pursued a Bachelor's degree in Biological Science with a focus on Biology, General. After completing their undergraduate studies, Bill went on to the University of Southern California from 2001 to 2003, where they earned their Master's degree in Public Health. Their emphasis during this program was on Biostatistics and Epidemiology. In 2007, they returned to the University of Southern California to pursue a further degree in Regulatory Science. Bill obtained a Master's degree in this field from 2007 to 2010. Finally, between 2010 and 2014, Bill Leitner undertook their highest level of education, completing a Doctor of Regulatory Science (DRSc) at the University of Southern California. It is worth noting that at some point, they also participated in an Executive Program on Influence and Negotiation Strategies at the Stanford University Graduate School of Business, although specific dates for this program are not provided.